Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Figures in the National Profile

 
This web page is archived for historical purposes and is no longer being updated. Newer data is available on the STD Data and Statistics page.
 

Chlamydia


Figure 1. Chlamydia—Rates by Sex, United States, 1990–2010

Figure 2. Chlamydia—Rates by Region, United States, 2001–2010

Figure 3. Chlamydia—Rates by State, United States and Outlying Areas, 2010

Figure 4. Chlamydia—Rates by County, United States, 2010

Figure 5. Chlamydia—Rates by Age and Sex, United States, 2010

Figure 6. Chlamydia—Rates by Race/Ethnicity, United States, 2001–2010

Figure 7. Chlamydia—Cases by Reporting Source and Sex, United States, 2001–2010

Figure 8. Chlamydia—Percentage of Reported Cases by Sex and Selected Reporting Sources, United States, 2010

Figure 9. Chlamydia—Prevalence by Age Group and Race/Ethnicity, National Health and Nutrition Examination Survey, 1999–2002

Figure 10. Chlamydia—Median State-specific Positivity Rates Among Women Aged 15–24 Years Tested in Family Planning Clinics, Infertility Prevention Project, United States, 1997–2010

Figure 11. Chlamydia—Positivity Among Women Aged 15–24 Years Tested in Family Planning Clinics, by State, Infertility Prevention Project, United States and Outlying Areas, 2010

Figure 12. Chlamydia—Trends in Positivity Rates Among Women Aged 15–24 Years Tested in Family Planning Clinics, by U.S. Department of Health and Human Services (HHS) Region, Infertility Prevention Project, 2006–2010

Figure 13. Chlamydia—Percentage of Nucleic Acid Amplification Tests Used Among Women Aged 15–24 Years Tested in Family Planning Clinics, by U.S. Department of Health and Human Services (HHS) Region, Infertility Prevention Project, 2006–2010

Gonorrhea


Figure 14. Gonorrhea—Rates, United States, 1941–2010

Figure 15. Gonorrhea—Rates by Sex, United States, 1990–2010

Figure 16. Gonorrhea—Rates by Region, United States, 2001–2010

Figure 17. Gonorrhea—Rates by State, United States and Outlying Areas, 2010

Figure 18. Gonorrhea—Rates by County, United States, 2010

Figure 19. Gonorrhea—Rates by Age and Sex, United States, 2010

Figure 20. Gonorrhea—Rates by Age Among Women Aged 15–44 Years, United States, 2001–2010

Figure 21. Gonorrhea—Rates by Age Among Men Aged 15–44 Years, United States, 2001–2010

Figure 22. Gonorrhea—Rates by Race/Ethnicity, United States, 2001–2010

Figure 23. Gonorrhea—Cases by Reporting Source and Sex, United States, 2001–2010

Figure 24. Gonorrhea—Percentage of Reported Cases by Sex and Selected Reporting Sources, United States, 2010

Figure 25. STD Surveillance Network (SSuN) —Proportion of MSM, MSW, and Women Among Interviewed Gonorrhea Cases by Site, 2010

Figure 26. Gonorrhea—Positivity Among Women Aged 15–24 Years Tested in Family Planning Clinics, by State, Infertility Prevention Project, United States and Outlying Areas, 2010

Figure 27. Gonococcal Isolate Surveillance Project (GISP)—Location of Participating Sentinel Sites and Regional Laboratories, United States, 2010

Figure 28. Gonococcal Isolate Surveillance Project (GISP)—Distribution of Minimum Inhibitory Concentrations (MICs) to Ceftriaxone Among GISP Isolates, 2006–2010

Figure 29. Gonococcal Isolate Surveillance Project (GISP)—Distribution of Minimum Inhibitory Concentrations (MICs) to Cefixime Among GISP Isolates, 2006 and 2009–2010

Figure 30. Gonococcal Isolate Surveillance Project (GISP)—Distribution of Minimum Inhibitory Concentrations (MICs) to Azithromycin Among GISP Isolates, 2006–2010

Figure 31. Gonococcal Isolate Surveillance Project (GISP)—Percentage of Neisseria gonorrhoeae Isolates with Resistance or Intermediate Resistance to Ciprofloxacin, 1990–2010

Figure 32. Gonococcal Isolate Surveillance Project (GISP)—Penicillin, Tetracycline, and Ciprofloxacin Resistance Among GISP Isolates, 2010

Figure 33. Gonococcal Isolate Surveillance Project (GISP)—Drugs Used to Treat Gonorrhea Among GISP Participants, 1988–2010

Syphilis


Figure 34. Syphilis—Reported Cases by Stage of Infection, United States, 1941–2010

Figure 35. Primary and Secondary Syphilis—Rates by Sex and Male-to-Female Rate Ratios, United States, 1990–2010

Figure 36. Primary and Secondary Syphilis—Rates by Region, United States, 2001–2010

Figure 37. Primary and Secondary Syphilis—Rates by State, United States and Outlying Areas, 2010

Figure 38. Primary and Secondary Syphilis—Rates by County, United States, 2010

Figure 39. Primary and Secondary Syphilis—Rates by Age and Sex, United States, 2010

Figure 40. Primary and Secondary Syphilis—Rates by Age Among Women Aged 15–44 Years, United States, 2001–2010

Figure 41. Primary and Secondary Syphilis—Rates by Age Among Men Aged 15–44 Years, United States, 2001–2010

Figure 42. Primary and Secondary Syphilis—Rates by Race/Ethnicity, United States, 2001–2010

Figure 43. Primary and Secondary Syphilis—Reported Cases by Stage, Sex, and Sexual Behavior, United States, 2010

Figure 44. Primary and Secondary Syphilis—Reported Cases by Sex, Sexual Behavior, and Race/Ethnicity, United States, 2010

Figure 45. Primary and Secondary Syphilis—Reported Cases by Reporting Source and Sex, United States, 2001–2010

Figure 46. Primary and Secondary Syphilis—Percentage of Reported Cases by Sex, Sexual Behavior, and Selected Reporting Sources, 2010

Figure 47. Congenital Syphilis—Reported Cases Among Infants by Year of Birth and Rates of Primary and Secondary Syphilis Among Women, United States, 2001–2010

Other Sexually Transmitted Diseases


Figure 48. Chancroid—Reported Cases, United States, 1981–2010

Figure 49. Human Papillomavirus—Prevalence of High-risk and Low-risk Types Among Females Aged 14–59 Years, National Health and Nutrition Examination Survey, 2003–2006

Figure 50. Genital Warts—Initial Visits to Physicians’ Offices, United States, 1966–2010

Figure 51. STD Surveillance Network (SSuN) —Genital Warts—Prevalence Among Sexually Transmitted Disease (STD) Clinic Patients by Sex, Sex of Partners, and Site, 2010

Figure 52. Genital Herpes—Initial Visits to Physicians’ Offices, United States, 1966–2010

Figure 53. Herpes Simplex Virus Type 2—Seroprevalence in Non-Hispanic Whites and Non-Hispanic Blacks by Age Group, National Health and Nutrition Examination Survey, 1976–1980, 1988–1994, 1999–2004, 2005–2008

Figure 54. Trichomoniasis and Other Vaginal Infections—Women—Initial Visits to Physicians’ Offices, United States, 1966–2010

Top